title: Influence of co-incubation and cell number of platelets and polymorphonuclear leukocytes in cellular inhibition and activation phenomena.
abstract: Evidence indicates that complex interactions occur between blood platelets and polymorphonuclear leukocytes (PMN) referring to both activation and inhibition phenomena. We studied the influence of co-incubating activated PMN and platelets at varying cell counts in the production of two active metabolites, thromboxane A2 (TxA2) measured as thromboxane B2 (TxB2) and platelet activating factor (PAF). The decrease observed in the quantity of TxA2 synthesized by 2 x 10(8) platelets/ml in the presence of physiological PMN counts clearly indicates an inhibitory effect of PMN in AA-derived metabolites. This suggests there is an influence of PMN-released products on activated platelets, decreasing their capacity to synthesize TxA2. Moreover, we found that the addition of platelets, which do not make measurable quantities of PAF, to PMN suspensions significantly decreased the capacity of PMN to synthesize this mediator. Together with this inhibiting action we also observed an activating effect, in such a way that the more PMN were added to platelet suspensions the more TxA2 was produced. Conversely, the maximal amounts of PAF were synthesized when the highest platelet count suspensions were added to PMN. In summary, the results we present here clearly show cellular interactions between platelets and PMN that directly influence the amounts of metabolites synthesized by both cells.
authors.affiliation: Servicio Hemoterapia y Hemostasia, Hospital Clínic i Provincial, Universitat de Barcelona, Spain.
authors.forename: R
authors.initials: R
authors.lastname: Hernández
authors.forename: M
authors.initials: M
authors.lastname: Alemany
authors.forename: J
authors.initials: J
authors.lastname: Bozzo
authors.forename: A
authors.initials: A
authors.lastname: Ordinas
authors.forename: E
authors.initials: E
authors.lastname: Bastida
mesh_terms: D001792:Blood Platelets / Q000166:cytology*; D002450:Cell Communication / Q000502:physiology*; D006801:Humans; D007958:Leukocyte Count; D009504:Neutrophils / Q000166:cytology*; D010972:Platelet Activating Factor / Q000032:analysis; D015539:Platelet Activation / Q000502:physiology; D010974:Platelet Aggregation / Q000502:physiology; D010976:Platelet Count; D013928:Thromboxane A2 / Q000096:biosynthesis; D013929:Thromboxane B2 / Q000097:blood
chemical_list: D010972:Platelet Activating Factor; D013929:Thromboxane B2; D013928:Thromboxane A2